Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor

Chan, KK; Bass, AR

Chan, KK (reprint author), Hosp Special Surg, Dept Med, Div Rheumatol, New York, NY 10021 USA.

ANNALS OF THE RHEUMATIC DISEASES, 2019; 78 (7):